Peptonic Medical AB (publ) (“Peptonic” or the “Company”) has received part of the first order under the recently signed strategic distribution agreement with US-based Joylux
Peptonic Medical AB (publ) (“the Company” or “Peptonic”) announces that the plan meeting in the Company’s corporate reorganization will be held on 27 November 2025
Peptonic Medical AB (publ) (the “Company”) announces the reconstruction plan in the Company’s ongoing corporate restructuring (the “Reconstruction Plan”). The Reconstruction Plan has today been
Peptonic Medical AB (publ) (“Peptonic” or the “Company”) has entered into a strategic distribution agreement with Joylux Inc., a well-established provider of intimate wellness solutions
Peptonic Medical AB (publ) (“Peptonic” or the “Company”) announces that the Uppsala District Court today, on 19 September 2025, has approved the Company’s request to
Peptonic Medical AB (publ) (“Peptonic” or the “Company”) has today submitted a request to the Uppsala District Court to extend the ongoing corporate reconstruction by
